Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
News|Articles|November 2, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-11-04-2015
- Volume 11
- Issue 11
Lubrizol Introduces Topical Film
Author(s)Pharmaceutical Technology Editors
The Transform hydrate-able film from Lubrizol LifeSciences is compatible with a range of APIs.
Advertisement
Lubrizol LifeSciences announced the introduction of Transform, a topical film that offers wide API compatibility and simplified loading techniques, at the 2015 American Association of Pharmaceutical Scientists (AAPS) conference Oct. 25-29 at the Orange County Convention Center in Orlando, FL.
In a statement, the company reports that the addition of Particle Sciences and the acquisition of Vesta enables Lubrizol to leverage its core polymer chemistry into tailored solutions for novel implantable products and dermal drug delivery systems.
The Transform hydrate-able topical film make loading APIs for drug delivery fast and easy, the company reports, potentially eliminating additional raw materials and processing steps of lamination and multiple components.
The company reports that Transform is a cool, comfortable, transparent film for optimal aesthetics and patient relief, providing patient comfort.
Source:
Articles in this issue
almost 11 years ago
New Reagents and Reactions Advance Fluorination Chemistryalmost 11 years ago
CMOs Ride Continuing Strength of Small-Molecule Drug Sectoralmost 11 years ago
FDA Extends Compliance Dates for Drug Dispensersalmost 11 years ago
Ashland Presents Scientific Studies for Drug Formulationalmost 11 years ago
Xcelience Opens New Headquartersalmost 11 years ago
IPEC-America Suggests Improvements to FDA’s Inactive Ingredients Databasealmost 11 years ago
Catalent Expands Cold-Chain Capacity at Shanghai Facilityalmost 11 years ago
Croda's French Facility Receives EXCiPACT Certificationalmost 11 years ago
Capsugel Launches enTRinsic Drug Delivery Technology Platformalmost 11 years ago
Rx-360 Names Mark Paxton as New CEOAdvertisement
Related to this article
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Advertisement
Advertisement